WOMASTIN 1 vial (Carboplatin 450mg)

Ovarian cancer, lung cancer, head and neck cancers, and other malignant neoplasms as part of combination therapy.

The drug is administered slowly via intravenous infusion in hospital settings. Dosage and schedule are determined by the treating oncologist based on tumour type, patient weight, renal function, and overall health status.

Contraindications:

• Hypersensitivity to carboplatin or platinum-containing agents
  
  
• Severe bone marrow suppression
  
  
• Renal impairment
  
  
• Pregnancy and lactation
  
  
• Not for use in children
  
  

Side effects:

• Low white blood cells, platelets
  
  
• Nausea, vomiting
  
  
• Hearing loss (ototoxicity)
  
  
• Kidney dysfunction
  
  
• Peripheral neuropathy
  
  
• Hair loss
  
  
• Fatigue
  
  
• Allergic reactions